Bruker Corporation (NASDAQ: BRKR) is a Healthcare company (Medical - Devices) with a market capitalization of $9.4B. The Maz Rating grades it against the other companies in its sector.
Bruker Corporation's current Maz Rating and its five factor grades are for members: log in to see them.
At $61.36, Bruker Corporation trades at 2.7x sales and 4.1x book value, with an EV/EBITDA of 89.2. Over the last twelve months it generated about $3.5B of revenue and a net loss of $168M. It runs a gross margin of 47.9%, an operating margin of 0.0% and a net margin of -3.5%. It shows return on equity of -5.1%, return on invested capital of 0.0% and a free cash flow yield of 2.6%. On the balance sheet: a debt-to-equity ratio of 0.75 and a current ratio of 1.84. Over the past 52 weeks the share price ranged from $32.37 to $68.98, with a beta of 1.26.
Bruker Corporation pays a dividend yielding 0.33%. Its Maz Dividend Score is 1.03 out of 5, ranked against the other dividend payers in its sector (Safety 2.50, Growth 2.10, Yield 1.17, Consistency 1.92).
33 Wall Street analyst ratings cover the stock: 16 Buy, 15 Hold and 2 Sell, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.